COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1672: Articles 16711-16720  | Next

Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay
Xia, Z., Sacco, M., Ma, C., Townsend, J., Kitamura, N., Hu, Y., Ba, M., Szeto, T., Zhang, X., Meng, X., Zhang, F., Xiang, Y., Marty, M., Chen, Y., Wang, J.
10.1101/2021.03.15.435551 — Posted: 2021-03-16
phastSim: efficient simulation of sequence evolution for pandemic-scale datasets
De Maio, N., Weilguny, L., Walker, C. R., Turakhia, Y., Corbett-Detig, R., Goldman, N.
10.1101/2021.03.15.435416 — Posted: 2021-03-16
Immunoinformatic Approach for the identification of T Cell and B Cell Epitopes in the Surface Glycoprotein and Designing a Potent Multiepitope Vaccine Construct Against SARS-CoV-2 including the new UK variant
Krishnasamy, K., Selvaraj, G. F., Ramesh, K., Padmanabhan, P., Gopalan, V., Govindan, K., Chandran, A., Sivasubramanian, S.
10.1101/2021.03.15.435391 — Posted: 2021-03-16
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
Hunter, E., Koutsothanasi, C., Wilson, A., Santos, F. C., Salter, M., Powell, R., Dring, A., Brajer, P., Egan, B., Westra, J., Ramadass, A., Messner, W., Brunton, A., Lyski, Z., Vancheeswaran, R., Barlow, A., Pchejetski, D., Robbins, P., Mellor, J., Akoulitchev, A.
10.1101/2021.03.14.435295 — Posted: 2021-03-16
DNA spike-ins enable confident interpretation of SARS-CoV-2 genomic data from amplicon-based sequencing
Lagerborg, K. A., Normandin, E., Bauer, M. R., Adams, G., Figueroa, K., Loreth, C., Gladden-Young, A., Shaw, B., Pearlman, L., Shenoy, E. S., Hooper, D., Pierce, V. M., Zachary, K. C., Park, D. J., MacInnis, B. L., Lemieux, J. E., Sabeti, P. C., Reilly, S. K., Siddle, K. J.
10.1101/2021.03.16.435654 — Posted: 2021-03-16
Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
Staquicini, D. I., Tang, F. H. F., Markosian, C., Yao, V. J., Staquicini, F. I., Dodero Rojas, E., Contessoto, V. G., Davis, D., O'Brien, P., Habib, N., Smith, T. L., Bruiners, N., Sidman, R. L., Gennaro, M. L., Lattime, E. C., Libutti, S. K., Whitford, P. C., Burley, S. K., Onuchic, J. N., Arap, W., Pasqualini, R.
10.1101/2021.03.15.435496 — Posted: 2021-03-16
Cluster Analysis of SARS-CoV-2 Gene using Deep Learning Autoencoder: Gene Profiling for Mutations and Transitions
Miyake, J., Sato, T., Baba, S., Nakamura, H., Niioka, H., Nakazawa, Y.
10.1101/2021.03.16.435601 — Posted: 2021-03-16
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Walls, A. C., Miranda, M. C., Pham, M. N., Schaefer, A., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O'Connor, M. A., Shireff, L., Ferrell, D. E., Brunette, N., Kepl, E., Bowen, J. E., Zepeda, S. K., Starr, T., Hsieh, C.-L., Fiala, B., Wrenn, S., Pettie, D., Sydeman, C., Johnson, M., Blackstone, A., Ravichandran, R., Ogohara, C., Carter, L., Tilles, S. W., Rappuoli, R., O'Hagan, D. T., Van Der Most, R., Van Voorhis, W. C., McLellan, J. S., Kleanthous, H., Sheahan, T. P., Fuller, D. H., Villinger, F., Bloom, J., Pulendran, B., Baric, R., King, N. P., Veesler, D.
10.1101/2021.03.15.435528 — Posted: 2021-03-16
Understanding SARS-CoV-2 Infection and Dynamics with Long Term Wastewater based Epidemiological Surveillance
Tharak, A., Kopperi, H., Hemalatha, M., Kiran, U., Gokulan, C. G., Moharir, S., Mishra, R. K., Venkata Mohan, S.
10.1101/2021.03.15.21253574 — Posted: 2021-03-16
Shed the light on virus: virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus.
Yahnke, C. J., Rathnasinghe, R. J., Garcia-Sastre, A.
10.1101/2021.03.14.435337 — Posted: 2021-03-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).